PET scanning and measuring the impact of treatment

Christian Cohade, Richard L. Wahl

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Positron emission tomography (PET) scanning with F18-fluorodeoxyglucose or FDG is a becoming a standard method for tumor staging. The prediction and evaluation of therapy response are newer applications of FDG-PET. PET often offers an early read-out of treatment efficacy and is an attractive alternative to conventional anatomic assessments of treatment response. This article reviews the methods available with PET tomonitor therapy response. Disease specific applications of PET imaging are then reviewed. While FDG is the most commonly used radiotracer for PET, many other radioligands could be applied in the future.

Original languageEnglish
Pages (from-to)119-134
Number of pages16
JournalCancer Journal
Issue number2
StatePublished - Apr 1 2002


  • Cancer
  • FDG
  • Fluorodeoxyglucose
  • PET
  • Positron emission tomography
  • Radionuclide imaging
  • Response
  • Therapy


Dive into the research topics of 'PET scanning and measuring the impact of treatment'. Together they form a unique fingerprint.

Cite this